Serum immunoglobulin G levels and peritonitis in peritoneal dialysis patients

J Nephrol. 2015 Aug;28(4):511-5. doi: 10.1007/s40620-015-0176-2. Epub 2015 Mar 11.

Abstract

Background: Peritonitis is a frequent and serious complication of peritoneal dialysis (PD). Whether low immunoglobulin level is associated with PD-related peritonitis is unknown.

Methods: We conducted a prospective study to assess whether immunoglobulin levels at PD onset could predict the occurrence of peritonitis. All patients starting peritoneal dialysis between 01/2005 and 12/2010 at the University hospital of Besançon, France, were included in the study.

Results: Of 240 consecutive PD patients enrolled (mean follow-up 25 ± 12 months), 76 (32%) had at least one episode of peritonitis. Mean immunoglobulin (Ig)G level at PD start was lower in patients who subsequently experienced peritonitis (7.9 + 3.4 vs. 9.7 + 3.4 g/l, p = 0.005). An increased IgG level at PD onset was associated with a reduced risk of peritonitis [hazard ratio (HR) 0.88, 95% confidence interval (CI) 0.80-0.97 for each increase of 1 g/l in IgG, p = 0.008]. IgG level ≤6.4 g/l ("low IgG") was the best predictive value for the occurrence of subsequent peritonitis: 52 patients (24%) had low IgG levels. At multivariate analysis, both low IgG level (HR 2.49, 95% CI 1.32-4.69, p = 0.005) and diabetes (HR 2.78, 95% CI 1.49-5.20, p = 0.001) were predictive of the occurrence of peritonitis.

Conclusion: Low IgG levels predict the occurrence of PD-related peritonitis. Randomized studies should determine whether such patients could benefit from intravenous immunoglobulin administration.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Down-Regulation
  • Female
  • France
  • Hospitals, University
  • Humans
  • Immunoglobulin G / blood*
  • Male
  • Middle Aged
  • Peritoneal Dialysis / adverse effects*
  • Peritoneal Dialysis / mortality
  • Peritonitis / blood
  • Peritonitis / diagnosis
  • Peritonitis / etiology*
  • Peritonitis / mortality
  • Peritonitis / therapy
  • Predictive Value of Tests
  • Prospective Studies
  • Risk Factors

Substances

  • Biomarkers
  • Immunoglobulin G